Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Harvard Business School
AstraZeneca
Moodys
Mallinckrodt

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEVOBUPIVACAINE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Levobupivacaine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00437996 Comparative Affect of a Continuous Epidural Infusion of Clonidine During Labour. Prospective Double Blind Randomized Trial Completed Hospices Civils de Lyon Phase 3 2007-02-01 Addition of clonidine to an epidural mixture of local anaesthetic and morphine improves analgesia and reduces the frequency of motor blockade during epidural analgesia. several side effects are possible mostly somnolence and hypotension. Association of continuous clonidine infusion with low concentrations of levobupivacaïne and sufentanil was not studied during labour. The objective of this study is to compare the effectiveness and the side effects of a PCEA with levobupivacaïne 0,0625 % and sufentanil 0.25 microg.ml-1, without addition of clonidine, and with addition of clonidine at a concentrations of 2 microg.ml-1.
NCT00523289 Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block Unknown status Cristália Produtos Químicos Farmacêuticos Ltda. Phase 4 2007-10-01 The purpose of this study is to determine if bupivacaine (75% levobupivacaine plus 25% racemic bupivacaine) with vasoconstrictor is effective and safety as ropivacaine in brachial plexus block for orthopedic surgery.
NCT00523289 Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block Unknown status University of Sao Paulo Phase 4 2007-10-01 The purpose of this study is to determine if bupivacaine (75% levobupivacaine plus 25% racemic bupivacaine) with vasoconstrictor is effective and safety as ropivacaine in brachial plexus block for orthopedic surgery.
NCT00552864 Comparison of Ropivacaine and Levobupivacaine in High Thoracic Epidural Anesthesia Completed Centro Cardiologico Monzino Phase 4 2003-01-01 In High Thoracic Epidural Anesthesia (HTEA) the use of a local anesthetic (LA) with low cardiac toxicity is crucial as myocardial contractility is often already seriously impaired. The aim of this study is to compare the efficacy, doses and side effects of ropivacaine and levobupivacaine in patients submitted to coronary artery bypass graft with HTEA and general anesthesia. The primary end point is the amount of LA drug required to maintain a VAS < 4 when coughing in the first 24 postoperative hours.
NCT00621907 Study : LEVOBUPIVACAINE Versus Placebo Completed Centre Hospitalier Universitaire de Saint Etienne Phase 3 2008-03-01 The locoregional anaesthesia is increasingly important in surgical practice, often allowing to simplify per- and post-operative analgesia. caesarian occurs in 20 % of delivery leading to a longer hospitalization because of the pain resulting from the surgery. The Levobupivacaïne (Chirocaïne) administered through catheters placed in the caesarean scars, showed its efficiency in post-operative analgesia. Method : realization of a double blind prospective randomized study, control versus placebo Purpose : to show that the local administration of a unique dose of analgesia reduce the post-operative pain with a little or non-invasive technique
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Levobupivacaine Hydrochloride

Condition Name

Condition Name for Levobupivacaine Hydrochloride
Intervention Trials
Pain 18
Postoperative Pain 10
Pain, Postoperative 10
Anesthesia 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Levobupivacaine Hydrochloride
Intervention Trials
Pain, Postoperative 25
Fractures, Bone 4
Hip Fractures 3
Femoral Fractures 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Levobupivacaine Hydrochloride

Trials by Country

Trials by Country for Levobupivacaine Hydrochloride
Location Trials
France 15
Turkey 15
Egypt 14
Italy 11
Belgium 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Levobupivacaine Hydrochloride
Location Trials
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Levobupivacaine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Levobupivacaine Hydrochloride
Clinical Trial Phase Trials
Phase 4 74
Phase 3 18
Phase 2/Phase 3 7
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Levobupivacaine Hydrochloride
Clinical Trial Phase Trials
Completed 74
Recruiting 24
Unknown status 18
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Levobupivacaine Hydrochloride

Sponsor Name

Sponsor Name for Levobupivacaine Hydrochloride
Sponsor Trials
Cristália Produtos Químicos Farmacêuticos Ltda. 4
Pontificia Universidad Catolica de Chile 4
University Hospital, Antwerp 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Levobupivacaine Hydrochloride
Sponsor Trials
Other 167
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Harvard Business School
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.